RAFAEL BEGLUYAN: Open Payments
NPI 1740701572 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 15 payments from 5 companies in 2025. Trend: 2023 $1,249 · 2024 $647 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $322 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $139 |
| Amgen Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: EVOQUE, LifeVest, Repatha, Wegovy, LEQVIO.
Industry payments across CA — which companies pay providers there.
